Ohm, Thanks for sharing your calculations with

Ohm,

Thanks for sharing your calculations with the board.

It is a valiant act as there are many unknowns and twists ... it gives a good estimate and a invaluable decision-making tool.

You use a very conservative 12 for P/E (which is a good way to keep the feet on the ground) however, BioTech P/Es sometimes exhibit have much larger numbers ,. from a former post: current=32.19, trailing=68.57, forward=43.88 ( averaged from 481 companies).

Not trying to correct/contend with your calculations which are excellent and very well-grounded, just saying that your numbers are probably in the lower bracket of the range, which is the best way of make investment decisions.

However, what I really wanted to point out is that, apart from revenues from COVID, a large market (likely larger than COVID) will come from off-label use of Vyrologix. Once we get approved for anything the genie will be out of the bottle ... and, given the list of indications (that you now better than anybody else ) we will be off to the races.

It will be epic.